LINC01030

Across TCGA pan-cancer cohorts, LINC01030 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC01030 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher LINC01030 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01030 expression acts as an unfavorable survival marker, although some lineages such as ESCA and LAML show a favorable association.

UVM, THYM, and LUSC are the cancer types where LINC01030 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	All	0.331	0.807	<.001	72	view →
THYM	OS	Tertile	All	0.872	1.000	<.001	71	view →
LUSC	OS	Tertile	IV	0.057	0.786	.008	55	view →
ESCA	OS	Tertile	IV	0.743	0.290	.013	30	view →
LUAD	OS	Tertile	IV	0.237	0.628	.025	30	view →
OV	DFS	Quartile	IV	0.240	0.545	<.001	24	view →
LAML	DFS	Tertile	All	0.601	0.270	.001	18	view →
COAD	OS	Tertile	IV	0.196	0.669	.016	18	view →
DLBC	DFS	Median	III,IV	1.000	0.525	.013	16	view →
CHOL	DFS	Tertile	All	0.142	0.557	.007	15	view →
ACC	DFS	Tertile	All	0.399	0.683	.018	14	view →
LIHC	OS	Median	All	0.607	0.725	.016	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC01030–UVM (DFS)

Open the UVM breakdown →